Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection
2 clinical trials · Condition
◉ Watch Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection (NCT05472090) | Tonix Pharmaceuticals, Inc. | 2022-08-18 |
| Efficacy, Safety, Tolerability of AXA1125 in Fatigue After COVID-19 Infection (NCT05152849) | Axcella Health, Inc | 2021-12-15 |
Track Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection automatically
Every clearance here is in the API, with alerts when new ones post.